Showing results (181-190 of 499) with videos related to
Sort By:
Pageof 50
The Journal of Antimicrobial Chemotherapy|June 22, 2013
Mutation covariation of HIV-1 CRF07_BC reverse transcriptase during antiretroviral therapyZhenpeng Li, Yang Huang, Yabo Ouyang, et al.Journal of Virology|April 18, 2008
Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitorsYuxian He, Jianwei Cheng, Jingjing Li, et al.AIDS (London, England)|April 2, 2019
Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41Wei Xu, Jing Pu, Shan Su, et al.Vaccine|August 5, 2008
Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccinesWenjun Xiao, Lanying Du, Chao Liang, et al.Biomed Research International|May 23, 2017
Advancements in Developing Strategies for Sterilizing and Functional HIV CuresWei Xu, Haoyang Li, Qian Wang, et al.Molecules (Basel, Switzerland)|July 14, 2018
Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 StrainsFei Yu, Wen Li, Lili Wang, et al.Microbes and Infection|April 8, 2014
FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse modelCuiqing Ma, Zheng Liu, Wenjian Li, et al.Journal of Medical Virology|September 26, 2022
Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccinesJie Zhou, Zezhong Liu, Guangxu Zhang, et al.Journal of X-Ray Science and Technology|June 14, 2024
An optimized filter design approach for enhancing imaging quality in industrial linear acceleratorGang Chen, Zehuan Zhang, Shuo Xu, et al.Journal of Virology|April 24, 2015
Nonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine StrategyQian Wang, Wenwen Bi, Xiaojie Zhu, et al.Pageof 50